Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. If treatment fails, sources in the vicinity of the patient must be sought. Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days.

Type

Journal article

Journal

Nederlands tijdschrift voor geneeskunde

Publication Date

12/2008

Volume

152

Pages

2667 - 2671

Addresses

Erasmus MC-Centrum, afd. Medische Microbiologie en Infectieziekten, Rotterdam.

Keywords

Nasal Cavity, Humans, Staphylococcal Infections, Mupirocin, Treatment Outcome, Drug Therapy, Combination, Hygiene, Evidence-Based Medicine, Carrier State, Methicillin-Resistant Staphylococcus aureus